ATE125300T1 - Kontrolle der anhäufung von abweichenden expressionsvektoren während der fermentationsverfahren. - Google Patents

Kontrolle der anhäufung von abweichenden expressionsvektoren während der fermentationsverfahren.

Info

Publication number
ATE125300T1
ATE125300T1 AT90306853T AT90306853T ATE125300T1 AT E125300 T1 ATE125300 T1 AT E125300T1 AT 90306853 T AT90306853 T AT 90306853T AT 90306853 T AT90306853 T AT 90306853T AT E125300 T1 ATE125300 T1 AT E125300T1
Authority
AT
Austria
Prior art keywords
accumulation
during fermentation
expression vectors
fermentation processes
controlling
Prior art date
Application number
AT90306853T
Other languages
English (en)
Inventor
William Lawrence Muth
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Application granted granted Critical
Publication of ATE125300T1 publication Critical patent/ATE125300T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Alcoholic Beverages (AREA)
  • Fertilizers (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • General Preparation And Processing Of Foods (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT90306853T 1989-06-26 1990-06-22 Kontrolle der anhäufung von abweichenden expressionsvektoren während der fermentationsverfahren. ATE125300T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37157989A 1989-06-26 1989-06-26

Publications (1)

Publication Number Publication Date
ATE125300T1 true ATE125300T1 (de) 1995-08-15

Family

ID=23464539

Family Applications (1)

Application Number Title Priority Date Filing Date
AT90306853T ATE125300T1 (de) 1989-06-26 1990-06-22 Kontrolle der anhäufung von abweichenden expressionsvektoren während der fermentationsverfahren.

Country Status (13)

Country Link
US (1) US5824496A (de)
EP (1) EP0405858B1 (de)
JP (1) JPH0347081A (de)
AT (1) ATE125300T1 (de)
AU (1) AU617057B2 (de)
CA (1) CA2019696A1 (de)
DE (1) DE69020968T2 (de)
DK (1) DK0405858T3 (de)
ES (1) ES2076318T3 (de)
GR (1) GR3017703T3 (de)
HU (1) HUT54415A (de)
IE (1) IE67799B1 (de)
IL (1) IL94847A0 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395761A (en) * 1991-11-27 1995-03-07 Eli Lilly And Company Plasmid pHKY334, an expression vector for EK-BGH and host cells transformed therewith
US6406855B1 (en) 1994-02-17 2002-06-18 Maxygen, Inc. Methods and compositions for polypeptide engineering
US6335160B1 (en) 1995-02-17 2002-01-01 Maxygen, Inc. Methods and compositions for polypeptide engineering

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4529695A (en) * 1981-06-18 1985-07-16 Wisconsin Alumni Research Foundation Recombinant cloning vector, host for the vector, and method for using same
BR8304213A (pt) * 1982-08-06 1984-03-13 Univ Leland Stanford Junior Processo para controle do crescimento da celula e obtencao dos produtos celulares
JPS6158595A (ja) * 1984-08-28 1986-03-25 ジェネックス・コーポレイション 徴生物によるタンパク質規模生産方法

Also Published As

Publication number Publication date
IE902289A1 (en) 1991-01-16
DE69020968D1 (de) 1995-08-24
EP0405858B1 (de) 1995-07-19
ES2076318T3 (es) 1995-11-01
DE69020968T2 (de) 1995-12-21
US5824496A (en) 1998-10-20
IL94847A0 (en) 1991-04-15
EP0405858A2 (de) 1991-01-02
CA2019696A1 (en) 1990-12-26
IE67799B1 (en) 1996-05-01
IE902289L (en) 1990-12-26
GR3017703T3 (en) 1996-01-31
JPH0347081A (ja) 1991-02-28
AU5780590A (en) 1991-01-03
HU903975D0 (en) 1990-11-28
HUT54415A (en) 1991-02-28
DK0405858T3 (da) 1995-09-04
EP0405858A3 (en) 1992-04-29
AU617057B2 (en) 1991-11-14

Similar Documents

Publication Publication Date Title
ES2142363T3 (es) Materiales y metodos para la hipersecrecion de aminoacidos.
LU91304I2 (fr) A tryn-antithrombin alfa
DK0652960T3 (da) Cyklisk GMP-bindende, cyklisk GMP-specifikke phosphodiesterasematerialer og fremgangsmåder
DE69022540D1 (de) Verfahren zur 1,2 Dehydrogenierung der Azasteroiden.
ATE199570T1 (de) Selbst-replizierende episomale expressionsvektoren, welche gewebespezifische expression vermitteln
EP0644421A3 (de) Verfahren zur Überwachung eines Isomerisationsverfahrens.
EP0552240A4 (en) New method of treating depression
FI102971B (fi) Enantioselektiivinen polypeptidi, sen valmistus, sitä koodittava DNA j a geeni, sekä sitä ilmentävä mikro-organismi, ja menetelmä stereoisome erin valmistamiseksi
DK0562508T3 (da) Nyt knogle-relateret protein OSF-2, fremgangsmåde til dets fremstilling samt farmaceutisk præparat med indhold deraf
ES2075056T3 (es) Oxidasa de los d-aminoacidos.
EP0654084A4 (de) Molekulare klonierung der für die kollagennaseproduktion in clostridium histolyticum verantwortlichen gene.
DE69020968D1 (de) Kontrolle der Anhäufung von abweichenden Expressionsvektoren während der Fermentationsverfahren.
ATE228567T1 (de) Transformation von phaffia rhodozyma
DE3852448D1 (de) Verfahren zur Aufarbeitung von Destillationsrückständen, die bei der Reinigung von Caprolactam anfallen.
DE3688383D1 (de) Rekombinantes vektorsystem fuer metalloproteinase-inhibitorsequenz und dessen verwendung und herstellung nach dem rekombinant-dns-verfahren.
DE3886124D1 (de) Verfahren zur antistatischen Ausrüstung von Kunststoff-Formteilen.
ATE312193T1 (de) Microbiologische herstellung von l-ascorbinsäure
GR3030321T3 (en) Method for casein finishing of leather.
DE69329540D1 (de) Verfahren zur Herstellung von Proteaseinhibitoren
TW242161B (de)
AU614517B2 (en) Process for isomerisation of E-isomers of 6-(substituted methylene)-2-penems into the Z-isomers
ES2063240T3 (es) Nuevos derivados de acido amino-carboxilico.
FR2706494B1 (fr) Procédé pour la teinture dégradée de cuirs.
HUT52152A (en) Process for producing factor controlling gene expression
TW198014B (de)

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee